|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
3,780,000 |
Market
Cap: |
10.77(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.55 - $3.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AYTU BioPharma is a pharmaceutical company focused on commercializing therapeutics and consumer health products and developing therapeutics for pediatric-onset or difficult-to-treat diseases. Co. operates through two business segments: the BioPharma segment, consisting of prescription pharmaceutical products; and the Consumer Health segment, which consists of various consumer healthcare products. Co. also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
538,371 |
Total Buy Value |
$0 |
$0 |
$0 |
$148,920 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
5 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boyd Steven |
Director |
|
2020-03-10 |
4 |
S |
$0.99 |
$31,200,123 |
D/D |
(22,026,801) |
1 |
|
- |
|
Boyd Steven |
Director |
|
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
22,036,802 |
|
- |
|
Boyd Steven |
Director |
|
2020-03-10 |
4 |
OE |
$0.00 |
$15,264,157 |
D/D |
15,229,161 |
22,026,802 |
|
- |
|
Boyd Steven |
Director |
|
2020-03-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
18,119,637 |
|
- |
|
Boyd Steven |
Director |
|
2020-03-10 |
4 |
D |
$1.30 |
$1,933,931 |
D/D |
(1,487,639) |
18,119,637 |
|
- |
|
Boyd Steven |
Director |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
8,285,279 |
|
- |
|
Boyd Steven |
Director |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
335,279 |
8,285,279 |
|
- |
|
Mehta Ketan Bhupatrai |
|
|
2020-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
75,000 |
|
- |
|
Boyd Steven |
Director |
|
2019-12-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
7,950,000 |
2.17 |
- |
|
Boyd Steven |
Director |
|
2019-12-20 |
4 |
B |
$0.88 |
$22,880 |
D/D |
26,000 |
7,950,000 |
3.92 |
- |
|
Boyd Steven |
Director |
|
2019-12-19 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
7,924,000 |
2.17 |
- |
|
Boyd Steven |
Director |
|
2019-12-19 |
4 |
B |
$0.85 |
$44,870 |
D/D |
52,788 |
7,924,000 |
3.92 |
- |
|
Disbrow Joshua R. |
Chief Executive Officer |
|
2019-12-19 |
4 |
B |
$0.89 |
$48,824 |
D/D |
55,000 |
525,048 |
0.01 |
- |
|
Boyd Steven |
Director |
|
2019-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
7,871,212 |
|
- |
|
Boyd Steven |
Director |
|
2019-10-30 |
4 |
OE |
$0.88 |
$2,421,010 |
D/D |
2,751,148 |
7,871,212 |
|
- |
|
Boyd Steven |
Director |
|
2019-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
5,120,064 |
|
- |
|
Boyd Steven |
Director |
|
2019-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,120,064 |
5,120,064 |
|
- |
|
Green David A |
Chief Financial Officer |
|
2019-02-13 |
4 |
A |
$1.04 |
$5,189 |
D/D |
5,000 |
271,250 |
|
- |
|
Mehta Ketan Bhupatrai |
Chief Financial Officer |
|
2019-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
|
- |
|
Green David A |
Chief Financial Officer |
|
2018-12-21 |
4 |
S |
$0.81 |
$2,711 |
D/D |
(3,330) |
266,250 |
|
- |
|
Dockery Carl |
Director |
|
2018-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
152,663 |
|
- |
|
Macaluso Michael |
Director |
|
2018-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
202,738 |
|
- |
|
Green David A |
Chief Financial Officer |
|
2018-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
262,500 |
269,580 |
|
- |
|
Cantrell Gary |
Director |
|
2018-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
152,840 |
|
- |
|
Disbrow Jarrett |
Chief Operating Officer |
|
2018-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
337,500 |
359,475 |
|
- |
|
116 Records found
|
|
Page 3 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|